Image
|
Figure Caption
Fig. 2 EPI-X4 WSC02 analogues inhibit X4-tropic HIV-1 infection with increased potency. WSC02 derivatives with either a single amino acid substitution (A), two distinct amino acid substitutions (B) or a combination of amino acid substitutions (C) were tested against X4-tropic HIV-1. TZM-bl reporter cells were preincubated with serially diluted peptide and afterwards inoculated with the virus. Infection rates were determined by β-galactosidase assay 3 days later. Data were represented as mean ± SEM (n = 3).
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Acta Pharm Sin B